首页> 外文期刊>Transplantation: Official Journal of the Transplantation Society >A novel prognostic index for mortality in renal transplant recipients after hospitalization.
【24h】

A novel prognostic index for mortality in renal transplant recipients after hospitalization.

机译:肾移植患者住院后死亡率的新的预后指标。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

BACKGROUND: Prognostic indices that estimate long-term mortality are essential not only to compare different clinical studies and populations but also to perform the most appropriate therapeutic interventions. All-cause mortality is high after renal transplantation (RTx), but no prognostic index has focused on predicting mortality in RTx. We developed and tested a prognostic index for mortality in RTx after hospitalization. METHODS: We retrospectively analyzed survival in 1,293 RTx recipients who were randomly assigned to two groups: a modeling population (n=646), used to create the new index, and a testing population (n=647), used to test this index. Patients were stratified into three risk groups (low, medium, and high) by combining peritransplant risk factors for mortality (beta-coefficient), using a simple eight-point check list: age, pretransplant cardiovascular disease, renal dysfunction at discharge, cardiac hypertrophy, vascular calcification, diabetes, time on dialysis, and acute tubular necrosis. RESULTS: Overall lower survival rates were observed with increasing risk classes in the testing population (log-rank test=18; P=0.0001). The 8-year survival rates ranged from 94% in the lowest-risk group to 59% in the highest-risk group. The area under the receiver operating characteristic curve was 0.63. Mortality risk (Cox analysis) significantly increased with increasing risk classes (medium risk: relative risk=3.8, 95% confidence interval=1.5-9.5, P=0.004; high risk: relative risk=6.3, 95% confidence interval=2.4-16.2, P=0.0001). CONCLUSIONS: This simple prognostic index applicable at the bedside may accurately predict survival in RTx recipients after discharge. Consequently, targeted treatment interventions may be indicated for minimizing mortality, especially in high-risk groups.
机译:背景:估计长期死亡率的预后指标不仅对比较不同的临床研究和人群至关重要,而且对于执行最合适的治疗干预措施也至关重要。肾移植(RTx)后全因死亡率很高,但尚无预后指标集中于预测RTx的死亡率。我们开发并测试了住院后RTx死亡率的预后指标。方法:我们回顾性分析了1,293例RTx受体的生存率,这些受体被随机分为两组:用于创建新指标的建模人群(n = 646)和用于测试该指标的测试人群(n = 647)。通过使用简单的八点检查表结合移植期间的死亡率高危因素(β系数),将患者分为三个风险组(低,中和高),包括年龄,移植前心血管疾病,出院时肾功能不全,心脏肥大,血管钙化,糖尿病,透析时间和急性肾小管坏死。结果:在测试人群中,随着风险类别的增加,总体生存率降低(对数秩检验= 18; P = 0.0001)。 8年生存率的范围从最低风险组的94%到最高风险组的59%。接收器工作特性曲线下的面积为0.63。死亡率风险(Cox分析)随着风险类别的增加而显着增加(中等风险:相对风险= 3.8,95%置信区间= 1.5-9.5,P = 0.004;高风险:相对风险= 6.3,95%置信区间= 2.4-16.2 ,P = 0.0001)。结论:适用于床旁的这一简单的预后指标可以准确预测出院后RTx接受者的生存。因此,可能需要针对性的治疗干预措施以最大程度地降低死亡率,尤其是在高危人群中。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号